BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31981856)

  • 1. Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients.
    Basso L; Bönke L; Aust S; Gärtner M; Heuser-Collier I; Otte C; Wingenfeld K; Bajbouj M; Grimm S
    J Psychiatr Res; 2020 Apr; 123():1-8. PubMed ID: 31981856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroconvulsive therapy in treatment resistant depression: What is new?].
    Kaliora SC
    Psychiatriki; 2021 Dec; 32(Supplement I):82-89. PubMed ID: 34990383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review.
    Veraart JKE; Smith-Apeldoorn SY; Spaans HP; Kamphuis J; Schoevers RA
    J Affect Disord; 2021 Feb; 281():82-89. PubMed ID: 33307338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.
    Rybakowski JK; Bodnar A; Krzywotulski M; Chlopocka-Wozniak M; Michalak M; Rosada-Kurasinska J; Bartkowska-Sniatkowska A
    J ECT; 2016 Sep; 32(3):164-8. PubMed ID: 27008330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression.
    Zavaliangos-Petropulu A; McClintock SM; Khalil J; Joshi SH; Taraku B; Al-Sharif NB; Espinoza RT; Narr KL
    J Affect Disord; 2023 Jul; 333():161-171. PubMed ID: 37060953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.
    Diamond PR; Farmery AD; Atkinson S; Haldar J; Williams N; Cowen PJ; Geddes JR; McShane R
    J Psychopharmacol; 2014 Jun; 28(6):536-44. PubMed ID: 24699062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression.
    Weeks HR; Tadler SC; Smith KW; Iacob E; Saccoman M; White AT; Landvatter JD; Chelune GJ; Suchy Y; Clark E; Cahalan MK; Bushnell L; Sakata D; Light AR; Light KC
    PLoS One; 2013; 8(7):e69809. PubMed ID: 23922809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy].
    Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł
    Psychiatr Pol; 2014; 48(1):49-58. PubMed ID: 24946434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effects of ketamine and ECT: A pilot comparison.
    Sharma RK; Kulkarni G; Kumar CN; Arumugham SS; Sudhir V; Mehta UM; Mitra S; Thanki MV; Thirthalli J
    J Affect Disord; 2020 Nov; 276():260-266. PubMed ID: 32697707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study.
    Zou L; Min S; Chen Q; Li X; Ren L
    Brain Behav; 2021 Jan; 11(1):e01775. PubMed ID: 33305900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
    Ekstrand J; Fattah C; Persson M; Cheng T; Nordanskog P; Åkeson J; Tingström A; Lindström MB; Nordenskjöld A; Movahed Rad P
    Int J Neuropsychopharmacol; 2022 May; 25(5):339-349. PubMed ID: 35020871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.